Your browser is no longer supported. Please, upgrade your browser.
TECH [NASD]
Bio-Techne Corporation
Index- P/E94.46 EPS (ttm)4.39 Insider Own0.50% Shs Outstand38.69M Perf Week2.84%
Market Cap15.95B Forward P/E58.19 EPS next Y7.12 Insider Trans-45.01% Shs Float38.59M Perf Month10.83%
Income174.80M PEG6.30 EPS next Q1.55 Inst Own94.30% Short Float1.00% Perf Quarter19.21%
Sales799.00M P/S19.97 EPS this Y135.60% Inst Trans-0.67% Short Ratio1.86 Perf Half Y56.09%
Book/sh39.34 P/B10.54 EPS next Y16.67% ROA8.60% Target Price422.78 Perf Year93.86%
Cash/sh7.35 P/C56.40 EPS next 5Y15.00% ROE12.40% 52W Range200.09 - 423.09 Perf YTD30.53%
Dividend1.28 P/FCF105.52 EPS past 5Y15.00% ROI6.30% 52W High-2.47% Beta1.11
Dividend %0.31% Quick Ratio3.70 Sales past 5Y10.30% Gross Margin66.60% 52W Low106.23% ATR13.01
Employees2300 Current Ratio4.60 Sales Q/Q-39.10% Oper. Margin23.40% RSI (14)59.71 Volatility2.65% 3.21%
OptionableYes Debt/Eq0.15 EPS Q/Q-66.20% Profit Margin21.90% Rel Volume0.70 Prev Close414.51
ShortableYes LT Debt/Eq0.14 EarningsMay 06 BMO Payout28.20% Avg Volume207.02K Price412.65
Recom1.80 SMA204.48% SMA507.01% SMA20032.97% Volume113,463 Change-0.45%
Mar-08-21Upgrade Stephens Equal-Weight → Overweight $380 → $425
Feb-23-21Upgrade Stifel Hold → Buy $435
Jan-25-21Reiterated The Benchmark Company Buy $320 → $410
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $340
Sep-30-20Initiated Atlantic Equities Overweight $365
Jul-15-20Downgrade Stephens Overweight → Equal-Weight
May-27-20Downgrade Stifel Buy → Hold $245 → $260
May-14-20Initiated The Benchmark Company Buy $290
Jan-08-20Resumed Stephens Overweight $250
Jan-08-20Initiated Wells Fargo Equal Weight $230
Jan-07-20Initiated Citigroup Neutral $235
Nov-15-19Initiated Stifel Buy
Jul-02-19Upgrade Janney Neutral → Buy $200 → $270
Jan-14-19Upgrade Stephens Equal-Weight → Overweight
Oct-31-18Downgrade Craig Hallum Buy → Hold
Oct-17-18Initiated Goldman Neutral $190
Jun-15-18Initiated Argus Buy $185
Jul-13-17Initiated Wells Fargo Market Perform
Feb-09-17Initiated Citigroup Buy $115
Jan-18-17Initiated Deutsche Bank Buy $115
Apr-19-21 12:53PM  
Apr-15-21 07:49AM  
07:00AM  
Apr-14-21 07:00AM  
Apr-08-21 07:00AM  
Apr-06-21 04:01PM  
07:00AM  
Mar-29-21 07:00AM  
Mar-26-21 07:00AM  
Mar-23-21 07:00AM  
Mar-15-21 07:00AM  
Mar-11-21 12:54PM  
Mar-10-21 10:31AM  
Mar-08-21 07:00AM  
Mar-04-21 08:12AM  
06:37AM  
Mar-03-21 04:45PM  
Mar-02-21 07:00AM  
Mar-01-21 07:00AM  
Feb-23-21 07:00AM  
Feb-22-21 06:53AM  
Feb-18-21 01:15PM  
Feb-16-21 07:00AM  
Feb-11-21 07:00AM  
Feb-10-21 11:31AM  
07:00AM  
Feb-08-21 07:30AM  
Feb-03-21 01:00PM  
07:00AM  
Feb-02-21 03:30PM  
07:08AM  
06:45AM  
06:30AM  
06:30AM  
Jan-30-21 01:19PM  
Jan-28-21 07:00AM  
Jan-14-21 07:00AM  
Jan-08-21 06:54AM  
Dec-21-20 10:03AM  
07:00AM  
Dec-09-20 03:44AM  
Dec-08-20 12:28PM  
Dec-02-20 07:00AM  
Nov-25-20 07:30AM  
Nov-11-20 07:00AM  
Nov-09-20 10:38AM  
Nov-05-20 10:01PM  
06:30AM  
06:30AM  
Nov-04-20 07:00AM  
Nov-02-20 07:00AM  
Oct-28-20 07:30AM  
Oct-26-20 07:30AM  
Oct-19-20 07:00AM  
Oct-15-20 07:00AM  
Oct-13-20 09:37AM  
07:00AM  
Oct-01-20 07:00AM  
Sep-30-20 07:00AM  
Sep-28-20 08:36PM  
Sep-23-20 07:00AM  
Sep-22-20 07:00AM  
Sep-21-20 07:00AM  
Sep-17-20 07:00AM  
Sep-15-20 03:41PM  
Sep-11-20 02:57PM  
Sep-08-20 07:00AM  
Sep-03-20 07:00AM  
Aug-19-20 08:00AM  
Aug-11-20 07:00AM  
Aug-06-20 06:00AM  
06:00AM  
Aug-04-20 03:31PM  
07:25AM  
07:20AM  
06:30AM  
06:30AM  
Aug-03-20 07:00AM  
07:00AM  
Jul-22-20 11:23AM  
Jul-21-20 07:09PM  
07:00AM  
Jul-20-20 07:00AM  
Jul-13-20 10:09AM  
07:00AM  
Jun-11-20 07:00AM  
Jun-09-20 07:00AM  
Jun-08-20 12:51PM  
07:00AM  
Jun-04-20 10:20AM  
May-27-20 07:00AM  
May-26-20 03:00AM  
May-25-20 11:37AM  
May-20-20 08:12AM  
May-19-20 04:05PM  
May-18-20 06:00PM  
May-11-20 11:32AM  
May-07-20 10:35AM  
May-04-20 01:26PM  
Apr-30-20 08:30PM  
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates in two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment offers proteins and reagent solutions, including cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and T-Cell activation technologies. This segment also provides manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including Food and Drug Administration -regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for original equipment manufacturers and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays comprising the ExoDx Prostate test for prostate cancer diagnosis. This segment also manufactures and sells tissue-based in-situ hybridization assays for research and clinical use. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kummeth Charles R.Chief Executive OfficerFeb 16Option Exercise94.3530,0002,830,500176,269Feb 18 04:38 PM
Furlow Brenda S.SVP - General CounselFeb 12Option Exercise106.5910,0001,065,90016,124Feb 17 04:42 PM
Hippel JamesChief Financial OfficerFeb 12Option Exercise106.5910,0001,065,90019,137Feb 17 04:46 PM
Hippel JamesChief Financial OfficerFeb 12Sale400.3910,0004,003,9089,137Feb 17 04:46 PM
Furlow Brenda S.SVP - General CounselFeb 12Sale398.6410,0003,986,3526,124Feb 17 04:42 PM
Nusse RoelandDirectorFeb 08Option Exercise67.476,000404,85012,765Feb 10 04:26 PM
Nusse RoelandDirectorFeb 08Sale385.086,0002,310,4816,765Feb 10 04:26 PM
Eansor Norman DavidPresident-Protein SciencesFeb 05Option Exercise106.5932,9333,510,32834,251Feb 09 05:24 PM
Kelderman KimPres. Diagnostics & GenomFeb 05Sale388.45823319,694845Feb 09 06:31 PM
Eansor Norman DavidPresident-Protein SciencesFeb 05Sale380.6832,93312,537,0231,318Feb 09 05:24 PM
Kummeth Charles R.Chief Executive OfficerJan 15Sale344.0020,0006,880,000146,269Jan 20 04:42 PM
Hippel JamesChief Financial OfficerJan 11Option Exercise106.5910,0001,065,90019,137Jan 13 05:18 PM
Hippel JamesChief Financial OfficerJan 11Sale333.6310,0003,336,3229,137Jan 13 05:18 PM
Kummeth Charles R.Chief Executive OfficerDec 07Sale308.005,0001,540,000166,269Dec 09 04:28 PM
Furlow Brenda S.SVP - General CounselNov 30Option Exercise106.5911,7951,257,22916,981Dec 02 06:01 PM
Furlow Brenda S.SVP - General CounselNov 30Sale301.9410,8573,278,1266,124Dec 02 06:01 PM
BAUMGARTNER ROBERT VDirectorNov 18Option Exercise66.905,000334,50014,612Nov 20 04:29 PM
BAUMGARTNER ROBERT VDirectorNov 18Sale303.335,0001,516,6759,612Nov 20 04:29 PM
Hippel JamesChief Financial OfficerNov 11Option Exercise106.597,391787,80716,528Nov 12 06:59 PM
Hippel JamesChief Financial OfficerNov 11Sale307.057,3912,269,4299,137Nov 12 06:59 PM
Hippel JamesChief Financial OfficerNov 09Option Exercise106.593,600383,72412,737Nov 12 06:59 PM
Seth AlpnaDirectorNov 09Option Exercise145.755,023732,1187,162Nov 19 12:27 PM
Seth AlpnaDirectorNov 09Sale306.625,0231,540,1672,139Nov 19 12:27 PM
Hippel JamesChief Financial OfficerNov 09Sale309.793,6001,115,2519,137Nov 12 06:59 PM
HIGGINS JOHN LDirectorNov 06Option Exercise70.355,000351,7509,412Nov 10 04:53 PM
STEER RANDOLPH CDirectorNov 06Option Exercise68.6210,000686,25015,112Nov 10 06:00 PM
Kummeth Charles R.Chief Executive OfficerNov 06Option Exercise86.2525,1572,169,791186,644Nov 10 06:04 PM
STEER RANDOLPH CDirectorNov 06Sale301.9910,0003,019,9485,112Nov 10 06:00 PM
HIGGINS JOHN LDirectorNov 06Sale300.355,0001,501,7444,412Nov 10 04:53 PM
Hippel JamesChief Financial OfficerNov 05Option Exercise108.498,809955,68817,946Nov 06 04:47 PM
Hippel JamesChief Financial OfficerNov 05Sale286.128,8092,520,4579,137Nov 06 04:47 PM
Hippel JamesChief Financial OfficerNov 04Option Exercise108.497,100770,27916,237Nov 06 04:47 PM
Hippel JamesChief Financial OfficerNov 04Sale274.007,1001,945,4279,137Nov 06 04:47 PM
Eansor Norman DavidPresident-Protein SciencesAug 09Option Exercise0.002,17402,174Aug 11 06:21 PM
Furlow Brenda S.SVP - General CounselAug 09Option Exercise0.001,72406,035Aug 11 06:22 PM
Kummeth Charles R.Chief Executive OfficerAug 09Option Exercise0.0021,2910173,774Aug 11 06:20 PM
Hippel JamesChief Financial OfficerAug 09Option Exercise0.004,438011,321Aug 11 06:21 PM
Furlow Brenda S.SVP - General CounselJul 09Option Exercise108.499,079984,98113,390Jul 13 04:02 PM
Furlow Brenda S.SVP - General CounselJul 09Sale275.769,0792,503,6524,311Jul 13 04:02 PM
Hippel JamesChief Financial OfficerJul 07Option Exercise108.492,577279,57911,884Jul 08 05:47 PM
Hippel JamesChief Financial OfficerJul 07Sale271.432,577699,4829,307Jul 08 05:47 PM
Hippel JamesChief Financial OfficerJul 06Option Exercise108.4921,5022,332,75230,809Jul 08 05:47 PM
Hippel JamesChief Financial OfficerJul 06Sale271.6121,5025,840,1529,307Jul 08 05:47 PM
WIENS HAROLD JDirectorMay 29Option Exercise101.193,985403,2428,828Jun 02 05:13 PM
Eansor Norman DavidPresident-Protein SciencesMay 29Option Exercise108.497,909858,0477,909Jun 01 05:58 PM
Eansor Norman DavidPresident-Protein SciencesMay 29Sale262.007,9092,072,1400Jun 01 05:58 PM
WIENS HAROLD JDirectorMay 29Sale260.003,9851,036,1004,843Jun 02 05:13 PM
Furlow Brenda S.SVP - General CounselMay 28Option Exercise105.517,595801,35810,306Jun 01 05:58 PM
Eansor Norman DavidPresident-Protein SciencesMay 28Option Exercise108.493,448374,0743,448Jun 01 05:58 PM
Eansor Norman DavidPresident-Protein SciencesMay 28Sale260.193,448897,1340Jun 01 05:58 PM
Furlow Brenda S.SVP - General CounselMay 28Sale260.145,9951,559,5334,311Jun 01 05:58 PM
Kummeth Charles R.Chief Executive OfficerMay 26Option Exercise86.2521,1591,824,964151,148May 28 05:41 PM
Eansor Norman DavidPresident-Protein SciencesMay 22Option Exercise104.0412,6001,310,93712,600May 26 05:13 PM
Eansor Norman DavidPresident-Protein SciencesMay 22Sale267.9312,6003,375,9260May 26 05:13 PM
BAUMGARTNER ROBERT VDirectorMay 21Option Exercise70.355,000351,75014,221May 26 05:13 PM
Eansor Norman DavidPresident-Protein SciencesMay 21Option Exercise94.3511,0371,041,34111,037May 26 05:13 PM
BAUMGARTNER ROBERT VDirectorMay 21Sale266.425,0001,332,1179,221May 26 05:13 PM
Eansor Norman DavidPresident-Protein SciencesMay 21Sale267.4911,0372,952,3160May 26 05:13 PM
WIENS HAROLD JDirectorMay 06Option Exercise87.344,260372,0689,481May 08 04:17 PM
WIENS HAROLD JDirectorMay 06Sale250.004,2601,065,0005,221May 08 04:17 PM
WIENS HAROLD JDirectorApr 30Option Exercise91.784,000367,1209,221May 04 04:35 PM
WIENS HAROLD JDirectorApr 30Sale225.004,000900,0005,221May 04 04:35 PM